iMedicor, the only HIPAA-compliant solution for interoperable health information transfer that is offered at no cost to healthcare providers, recently announced that the company has partnered with myLEADERBOARD, Inc. to complete the development of a mobile application of its online communications platform. iMedicor electronic medical record (EMR) enables doctors to collaborate and exchange records in real time and also allows pharmaceutical companies to deliver targeted educational marketing materials to nationwide healthcare providers in a cost-effective manner.
Due to the growing demand by physicians, iMedicor is joining forces with myLEADERBOARD, a developer of mobile software solutions, to provide electronic services to the large majority of doctors who use handheld devices for business purposes. The myLEADERBOARD proprietary mobile platform supports iPhone, BlackBerry, Android, Windows Mobile and Palm, as well as mobile web for browser-only enabled cell phones.
Fred Zolla, iMedicor’s chief executive officer, stated, “iMedicor is working with myLEADERBOARD to deliver this new functionality within 60 to 90 days. According to Manhattan Research, over 64 percent of all physicians use mobile devices, such as an iPhone and / or BlackBerry, in their daily practices, up 20 percent between 2008 and 2009. We look forward to integrating these and other proven mobile applications to enhance iMedicor’s ability to support physician workflow.”
About QualityStocks:
QualityStocks’ Small Cap Stock Newsletter is a free service that collects data from hundreds of Small-Cap online Investment Newsletters into one free Daily Newsletter Report.
Sign up for “The QualityStocks Daily Newsletter” please visit www.QualityStocks.net
The Quality Stocks Daily Stock Report http://video.qualitystocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks “Ones to Watch” http://Gotstocks.QualityStocks.net
Please see disclaimer on QualityStocks website: http://disclaimer.qualitystocks.net
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment